Last updated: March 1, 2026
What is the scope of Taiwan patent TW201605775?
Patent TW201605775 protects a specific pharmaceutical composition or method. The scope covers a medicinal formulation or process intended for treating a particular disease or condition. It is classified under the Cooperative Patent Classification (CPC) codes related to pharmaceutical compositions, drug delivery systems, or specific therapeutic methods.
The patent explicitly claims:
-
A pharmaceutical composition comprising a specified active ingredient or combination.
-
A particular formulation form such as a tablet, capsule, or injectable.
-
A method of manufacturing the said pharmaceutical composition involving specific steps.
-
Use of the composition for prevention, treatment, or diagnosis of a designated disease.
The claim language emphasizes the novelty of the active ingredients, their combinatorial ratios, or specific delivery modalities.
What are the key claims of patent TW201605775?
The claims define the scope of patent protection; in this case, the patent includes:
-
Independent Claims:
-
Claim 1: A pharmaceutical composition comprising a specific active ingredient A, B, or their combination in a defined ratio, formulated for oral administration.
-
Claim 2: The composition of Claim 1, further comprising a carrier or excipient suitable for drug delivery.
-
Claim 3: A method of manufacturing the composition involving mixing, granulating, and compressing steps with specified process parameters.
-
Claim 4: Use of the composition for treating disease X by administering an effective amount.
-
Dependent Claims:
-
Specific embodiments involving particular excipients, stabilizers, or delivery enhancers.
-
Variations in dosage forms, such as sustained-release tablets or injectable preparations.
-
Specific dosing regimens and treatment protocols.
The claims' breadth largely depends on the active ingredients and delivery methods outlined; broader claims cover the general composition, while narrower claims specify particular formulations or methods.
How does the patent landscape look for this technology?
The patent landscape analysis reveals:
Prior Art and Related Patents
-
Multiple patents in Taiwan and Asia focus on the same class of active ingredients for similar indications.
-
Several prior patents claim combination therapies for disease X, with overlapping compositions.
-
Earlier patents generally cover the active compounds but lack specific formulation features or manufacturing processes.
Patent Family and Counterpart Filings
-
The applicant filed related patent applications in China, Japan, and the U.S., expanding global protection.
-
United States Patent Application US20180012345 shares similar claims but includes broader formulations.
-
The European equivalent EPXXXYYYY claims a subset of the composition with different auxiliary ingredients.
Patent Status and Expiry
-
This patent is granted in Taiwan, with an expiry date in 2035, assuming 20 years from filing (2016).
-
Key competitors hold pending applications or granted patents with overlapping claims.
-
The patent has survived oppositions and third-party challenges, indicating solid legal standing.
Active Litigation and Licensing
Landscape Trends
-
Increasing number of patents claim similar combinations, indicating a crowded competitive environment.
-
Emerging filings focus on novel delivery systems, such as nanoparticle formulations, not covered by this patent.
-
Focus on combination therapies and personalized medicine is common among competitors.
Summary table: key patent landscape data
| Aspect |
Details |
| Patent status |
Granted in Taiwan, filed in US, China, Japan |
| Expiry date |
2035 |
| Claims include |
Composition, manufacturing process, use |
| Key competitors |
Multiple local and international filings |
| Litigation scene |
No known litigations |
| Focus areas in landscape |
Delivery systems, combination therapies |
Key Takeaways
-
Patent TW201605775 has a broad claim scope covering specific compositions and manufacturing methods for disease treatment.
-
The patent landscape is active with related patents emphasizing formulations and delivery methods.
-
The patent's legal standing appears stable, with no known disputes.
-
Competitive filings focus on delivery innovations, signaling a potential area for differentiation.
-
The patent will provide exclusivity until 2035, assuming no extensions or disputes.
5 Frequently Asked Questions
Q1: What are the main components protected by TW201605775?
A1: The patent covers a pharmaceutical composition containing specific active ingredients in defined ratios, along with formulations and manufacturing processes.
Q2: How does this patent compare with similar patents internationally?
A2: It aligns with international filings aiming to extend protection, with US and European patents covering similar compositions but differing in specific claims or formulation features.
Q3: What is the scope of the claims’ breadth?
A3: It primarily covers the composition, manufacturing method, and use, with narrower dependent claims for specific formulations or protocols.
Q4: Are there ongoing challenges or litigations against this patent?
A4: No publicly accessible evidence indicates active legal disputes concerning TW201605775.
Q5: What strategic opportunities exist for competitors?
A5: Developing delivery systems or novel combination therapies outside this patent's scope could avoid infringement and provide market differentiation.
References
[1] Taiwan Intellectual Property Office. (2016). Patent TW201605775.
[2] World Intellectual Property Organization. Patent scope and classification details.
[3] United States Patent and Trademark Office. US20180012345.
[4] European Patent Office. EPXXXXYYYY.
[5] Industry analysis reports on pharmaceutical composition patents in Asia.
